Istituto Superiore di Sanità   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Rome Italy (1941)

Organization Overview

First Clinical Trial
1992
NCT00004800
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Barbara Ensoli, MD, PhD | Istituto Superiore di Sanità | Istituto Superiore Sanita

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

HIV Infections (Phase 2)

Melanoma (Phase 1)

Multiple Sclerosis (Phase 3)

Neoplasm Metastasis (Phase 2)

Sarcoma (Phase 2)

Sarcoma, Kaposi (Phase 2)

Sclerosis (Phase 3)

Tobacco Use Disorder (Phase 1)

Whooping Cough (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 18
  • # of Trial APIs: 32